DON'T discount the humble maxi dress - Laura Whitmore's black and gold Sophia Kah number (paired with Pandora jewellery) proves the summer staple still has plenty of mileage.
Shop LBDs
DON'T discount the humble maxi dress - Laura Whitmore's black and gold Sophia Kah number (paired with Pandora jewellery) proves the summer staple still has plenty of mileage.
Shop LBDs
By Steven Reinberg
HealthDay ReporterWEDNESDAY, June 26 (HealthDay News) -- After suffering a stroke or a mini-stroke, patients are usually given aspirin to prevent clots that can cause another stroke. Now a new study suggests that adding the drug Plavix (clopidogrel) to the mix can reduce the risk of a second stroke by nearly a third over aspirin alone.
Both drugs target clotting agents in the blood, called platelets, preventing them from grouping together and forming clots. The drug combination is commonly used after a heart attack, but until now there hasn't been enough data to suggest it would work in stroke or mini-stroke, officially known as a transient ischemic attack (TIA).
"Giving two drugs that block platelets works a lot better than aspirin alone in people who have had a minor stroke or TIA," said researcher Dr. S. Claiborne Johnston, a professor of neurology at the University of California, San Francisco.
The trial was done in China, so whether the results would be the same in the United States isn't known. "They probably are, but we would like to see them confirmed," Johnston said.
To do so, a similar trial is under way in the United States with Johnston as the lead investigator. "We should have confirmation or no confirmation within a few years," he said.
Some doctors are treating stroke patients with this combination of drugs now, Johnston said. "This combination may be something [other] doctors can consider," he said.
The report was published June 26 in the online edition of the New England Journal of Medicine.
Most strokes are caused by blood clots that block blood vessels in the brain. These are called ischemic strokes. A TIA is also caused by a clot that dissipates in a short time. Both leave patients at risk for another stroke that could be more severe, the researchers said.
In the new phase 3 trial, more than 5,000 patients who had suffered a stroke or TIA within the previous 24 hours were randomly assigned to take either aspirin alone or aspirin plus Plavix for three months.
This three-month period is the most critical for repeat strokes, with 10 percent to 20 percent of people who have a TIA or minor stroke suffering a second stroke, the researchers said.
Within three months of starting the study, 8.2 percent of the patients taking the two-drug combo had another stroke, compared with 11.7 percent of those taking aspirin alone, the researchers found.
Dr. Rafael Alexander Ortiz, director of neuro-endovascular surgery and stroke at Lenox Hill Hospital in New York City, said these findings are important and, if confirmed, will change standard practice for some stroke patients.
"This is great news in terms of a positive outcome," said Ortiz, who was not involved with the study.
The U.S. Food and Drug Administration is warning consumers not to consume any juice products or other beverages from Juices Incorporated (aka Juices International and Juices Enterprises) of Brooklyn, N.Y. The company's carrot and beet juice products have the potential to be contaminated with Clostridium botulinum, a bacterium which can cause botulism, a serious and potentially fatal foodborne illness. Consumers are warned not to consume these products even if they do not look or smell spoiled.
Botulism can cause the following symptoms: general weakness; dizziness; double-vision; and trouble with speaking or swallowing. Difficulty in breathing, weakness of other muscles, abdominal distension and constipation may also be common symptoms. People experiencing these symptoms after consuming carrot or beet juice products from Juices Incorporated should seek immediate medical attention.
Although previously distributed in New York, New Jersey, Connecticut and Pennsylvania, Juices Incorporated products were recently found in retail establishments and restaurants in the New York City area, and consumers may have moved the products beyond this region.
The following Juices Incorporated juice products pose a particular concern for Clostridium botulinum contamination:
Carrot Juice DrinkCarrot & Beet Juice DrinkCarrot & Ginger DrinkDouble Trouble Carrot PunchGinger Beet JuiceBeet Juice DrinkThe products are packaged under the following brand names:
Juices IncorporatedJuices InternationalJuices EnterprisesOn October 7, 2010, the U.S. Department of Justice filed a complaint for permanent injunction against the owners of Juices Incorporated after FDA inspections revealed continuing violations of the Federal Food, Drug and Cosmetic Act, including insanitary conditions at the Juices Incorporated facility. Under a January 3, 2011 Consent Decree of Permanent Injunction (Consent Decree), the owners of Juices Incorporated are required to stop manufacturing and distributing any articles of food, including all juice products and other beverages, until they correct the food safety deficiencies and insanitary conditions at their facility.
Subsequently, on June 21, 2012, U.S. District Court Judge Sandra L. Townes for the Eastern District of New York issued an Order to Enforce Consent Decree after the owners of Juices Incorporated failed to comply with the requirements of the Consent Decree. FDA investigators recently confirmed that Juices Incorporated and its owners continue to manufacture and distribute juice products and other beverages in violation of the Consent Decree and the Court's Order to Enforce Consent Decree.
Although Clostridium botulinum has never been found inJuices Incorporated's juice products, FDA is concerned about the firm's continuing production of potentially hazardous juice products despite the requirements of the Consent Decree and Order to Enforce Consent Decree. Because the company was ordered not to manufacture or distribute any food, FDA is also warning consumers not to consume other Juices Incorporated beverages, including but not limited to: Ginger Beer Drink, Agony Peanut Punch, Front End Lifter Magnum Punch, Irish Sea Moss, Cashew Punch, Sorrel Drink, Pineapple Twist, Soursop Juice, and Corn Punch. The Federal Food, Drug and Cosmetic Act refers to unsanitary conditions as insanitary.
SOURCE: FDA, May 10, 2013
By Serena Gordon
HealthDay ReporterWEDNESDAY, June 26 (HealthDay News) -- Although there has been significant debate about whether calcium and vitamin D supplements are beneficial for older women, new research suggests that the answer may be yes for those who are taking hormone replacement therapy.
Women using HRT who also took daily supplements of calcium and vitamin D saw a 40 percent reduction in their rate of hip fractures compared to women who took placebo supplements, according to the study.
"We found that women who were on hormones had less hip fractures, and women who were on hormones and calcium and vitamin D supplements had even fewer hip fractures," said study author Dr. John Robbins, a professor of medicine at the University of California at Davis.
Results of the study were published online June 26 in the journal Menopause.
As many as half of all women over 50 will have an osteoporosis-related fracture in their lifetime, according to the U.S. Preventive Services Task Force (USPSTF). Osteoporosis is a condition caused by a loss of bone mass and density, which leaves bones fragile and more susceptible to fractures. Calcium is an important component in bone growth, and vitamin D helps the body absorb calcium.
What's not clear is if supplements of these nutrients are as helpful in keeping bones strong as they are from natural sources, such as diet. The USPSTF recently looked at the effect of 1,000 milligrams of daily calcium and 400 international units of vitamin D. In February, they concluded that women shouldn't take calcium and vitamin D supplements because the available evidence wasn't strong enough to show a significant benefit. They added that the benefits of higher doses are unknown.
The new study included data from the Women's Health Study on about 30,000 postmenopausal women between the ages of 50 and 79. Many of the women were taking hormone replacement therapy -- either estrogen alone or a combination of estrogen and progesterone.
Just over 16,000 women participated in the calcium and vitamin D portion of the study. They were randomly selected to receive either a placebo or 1,000 milligrams of calcium and 400 international units of vitamin D each day. The average follow-up time was about seven years.
The hormone therapy and the supplements together were the most effective treatment for reducing hip fracture risk. The researchers found that the combination reduced the risk of hip fracture by 57 percent.
Overall, the rate of hip fracture was 11 per 10,000 women per year for those who took both hormones and supplements. Women who took only hormones had a hip fracture rate of 18 per 10,000, while those who took only supplements had a hip fracture rate of 25 per 10,000. Women who received neither therapy had 22 hip fractures per 10,000 women.
Nicole Kidman, Rooney Mara, Carey Mulligan, Naomie Harris and Lynne Ramsay are to be celebrated at a 'women in film' party at this year's Cannes festival.
It was announced today that the IFP (Independent Filmmaker Project), Calvin Klein Collection and euphoria Calvin Klein will host their third annual event at L'Ecrin on 16 May as part of the 66th Cannes Film Festival.
GLAMOUR.com will be reporting from Cannes on the night to bring you all the action from the red carpet and inside the party, so make sure you're following us on Twitter for live updates.
Last year's attendees included Diane Kruger, Naomi Watts, Jessica Chastain, Lara Stone and Isla Fisher.
Cannes kicks off next Wednesday 15 May with a premiere of The Great Gatsby, with Leonardo DiCaprio, Carey Mulligan, Beyoncé and Jay-Z expected to be in attendance.
« Back to more Celebrity News
Bluesense theme designed by Make Money Online | Dosh Dosh
Bloggerized by Free Blogger Template